A B S T R A C T Pneumococcus-induced
INTRODUCTION
Thrombocytopenia, sometimes accompanied by thrombohemorrhagic complications, frequently accompanies infection with different strains of microorganisms (1) (2) (3) gregate and/or cause release of serotonin and nucleotides with the participation of a plasma/serum factor or factors (4) (5) (6) . We have identified the factor that interacts with pneumococcus to induce release of serotonin from human platelets as immunoglobulin. Our studies indicate that the release is induced by pneumococcal antigen-antibody complexes and that antibodies capable of supporting this reaction are present in the great majority, if not all, of normal human plasma and sera. This reaction between pneumococcus, antibody, and platelets may play an important etiologic role in the thrombocytopenia and/or thrombo-hemorrhagic (7) (8) (9) complications accompanying infections with this microorganism.
METHODS
Preparation of ['4C ]serotonin labeled platelets. The method of preparing washed platelets was modified from methods described previously (10, 11) . Venous blood (45 ml) was taken into 5 ml of acid citrate dextrose (ACD formula A) in 50-ml conical plastic culture tubes. The cellular constituents of the blood were separated from plasma by centrifugation at 2,300 g for 15 min at ambient temperature (22-250C) and then suspended in a volume of modified Tyrode's buffer equal in volume to the plasma volume. 40 yCi of ["C] serotonin (New England Nuclear, Boston, Mass.) were added to the 50-ml cell suspension and the mixture was incubated at 37'C for 30 min. The cellular constituents of the suspension were then removed by centrifugation at 2,300 g for 15 min and washed four times by resuspension in Tyrode's buffer. The cell mixture was then resuspended in sufficient buffer to reconstitute the mixture to the initial whole blood volume. The platelets were then separated from the other cellular elements by slow centrifugation at 190 g for 15 min, and the small number of red and white cells that remained were removed by centrifugation at 620 g for 60 s. Tyrode's buffer was modified in the following ways: the initial suspending buffer and that used for washing contained 0.03 M adenosine to prevent aggregation. Adenosine was omitted from the final suspending buffer. Calcium was omitted from all but the final suspending buffer. It was also omitted from the final suspending Suffer if plasma (as The Journal of Clinical Investigation Volume 56 October 1975*828-834 opposed to serum or isolated protein preparations) was used in the succeeding experiments. Bovine serum albumin was used at a concentration of 5% in the initial suspending buffer and at a concentration of 2%Fo thereafter. Platelet counts of the final suspension varied between 200,000 and 600,000/mm3 with less than 0.1% of contaminating red or white cells present.
Preparation of platelet-rich plasma, plasma, and sera. Normal platelet-rich plasma, plasma, and sera were obtained from volunteer donors between the ages of 21 and 40 yr who gave no history of previous pneumococcal infections or of any respiratory infections within the previous 2 mo.
Platelet-rich plasma was prepared from citrated whole blood by centrifugation at 190 g for 15 min, and contained 3-5 X 105 platelets/mm3. Plasma was prepared from citrated whole blood by centrifugation at 2,300 g for 15 min. Serum was prepared by allowing whole blood to clot 2 h at 37' C. The clot and formed elements were removed by centrifugation at 2,300 g for 15 min. Plasma and sera were used fresh or stored at -70'C.
IgG concentrations of normal sera were determined by radial immunodiffusion. To minimize the amount of normal IgG in the IgG myeloma proteins, whenever possible sera from patients having 4 g or more myeloma proteins/100 ml of serum were used. The class and light chain type were determined by double diffusion in agar by using specific rabbit antisera prepared according to the method of Fahey and McLaughlin (12) . The IgG subclasses were identified with specific rabbit antisera (13) . F(ab)a and Fc fragments of normal IgG were prepared as previously described (14) . All immunoglobulins had been dialyzed against 0.15 M sodium chloride and were diluted at least one part to four parts in Tyrode's buffer before use.
Fibrinogen was provided by Drs. Thomas Edgington and Edward Plow. It was prepared as previously described (15) Pneumococci were subcultured on blood agar plates in a 5% CO2 atmosphere. They were passed through mice if their activity in these experiments appeared to be decreasing and/or if they began to lose their capsules. For use in these studies, the pneumococci were grown for 16-18 h at 37'C in Trypticase soy broth in a 57% C02 atmosphere and harvested by centrifugation at 27,000 g for 30 min, rewashed four times in barbital-buffered saline, and suspended in approximately 1/20 of the culture volume of normal saline. Pneumococci were then heated for 1 h at 100'C to inactivate pneumolysin and stored at -70'C.
Before use they were diluted to the appropriate concentration in barbital-buffered saline (usually 8 X 108/ml).
Preparation of solid phase aizti-F(ab)2 antibody (anti-(Fab')2 beads). Anti-F(ab')2 sera were prepared in rabbits as described previously (16) and the globulin fraction isolated by precipitation with 50%o saturated ammonium sulfate. The antibody globulin was coupled to Sepharose 2B beads (Pharmacia Fine Chemicals) by cyanogen bromide as described elsewhere (16a). The globulin fraction from a pool of normal rabbit serum was similarly coupled to Sepharose 2B beads for use as a control.
Depletion of "releasing factor" from diluted plasma and serum was accomplished by incubating equal volumes of anti-F(ab)2 beads or control beads and diluted plasma or serum for 4 h at room temperature with constant rocking. The beads were then removed by centrifugation at 7,000 g for 5 min.
Release of radiolabeled serotonin from human platelets. FIGURE 1 The effect of the concentration of pneumococcus on platelet release of ["C] serotonin. Platelets, at a concentration of 2.4 X l0, were incubated with a decreasing concentration of pneumococcus beginning with 9.6 X 10'/ml and normal human serum or buffer. The ratio of platelets to pneumococci is indicated on the horizontal axis. Diluted serum in the absence of pneumococcus did not cause release beyond that seen with buffer in the absence of pneunmococcus. Type III pneumococcus was used.
Lactic dehydrogeniase activity. Lactic dehydrogenase activity was determined on a DuPont automated clinical analyzer (DuPont Instruments, Wilmington, Del.).
RESULTS
Demonstration of a releasing factor in normal humana plasma and serum participating in pneumococcal-induced release of ['4C]serotonin from human platelets. Large numbers of heat-killed pneumococci occasionally induced serotonin release in the absence of plasma or serum. However, when the number of pneumococci was reduced to approximately 2 X 108/ml or less, serum or plasma was necessary to support this release. In the following experiments a final concentration of pneumococci was chosen (usually between 7 and 9 X 107/ml) that produced no release in the absence of plasma or serum. Though a smaller number of platelets, (2 -6 X 107) per milliliter than pneumococci was routinely included in the reaction mixture, significant release was still seen when the pneumococcus concentration was reduced to A that of the platelets (Fig. 1) by monospecific solid phase anti-Fab antibody (Table IV); second, serum from an individual with severe pan immunoglobulin deficiency (IgG, IgA, IgD, IgM, less than 10 /Lg/ml) failed to support the release reaction ( Fig. 2 and Table I ); and third, the release reaction was supported by preparations of immunoglobulin G isolated from normal human sera (Table III) Release was not supported to a significant degree by five myeloma IgG preparations tested at 2 mg/ml. This contrasts with the ability of a normal IgG preparation to support release at concentrations as low as 0.05 mg/ml. DISCUSSION Septicemia with pneumococci and other bacteria, as well as infection with viruses and fungi, may be associated with thrombocytopenia with or without associated intravascular coagulation (1) (2) (3) (7) (8) (9) . The mechanism for this thrombocytopenia, however, often is not clear. Microorganisms interact with platelets in vitro in diverse ways. Some bacterial and viral products have a direct lytic effect on platelets (17, 18) . Yeast cell walls (zymosan) on the other hand, require participation of the alternative complement pathway as well as fibrinogen to induce platelet release (19) . One or more serum factors also participate in the interaction of several bacterial species with platelets. In this study, we have shown that for the pneumococcus and normal plasma or serum, the factor is immunoglobulin, without the participation of other plasma/serum factors. Solid phase anti-F(ab)2 antibody removed the releasing factor from plasma and serum, the factor was absent from the serum of an individual with severe pan immunoglobulin deficiency (though present in the sera of all normal individuals tested), and releasing factor was present in preparations of IgG isolated from single or pooled normal sera.
Immunoglobulins have been shown to induce platelet release either when participating in immune reactions as antigen-antibody complexes (20) (21) (22) (23) or by nonimmune mechanisms such as coating of glass or polymethylmethacrylate beads (24) . Aggregated immunoglobulins of all the IgG subclasses have been shown to induce platelet release in the absence of antigen or particulate matter (25, 26 (27, 28) . The ability of type III pneumococcus to induce aggregation in platelet-rich plasma suggests that pneumococcal-induced release is not simply the result of changes occurring in the platelet during washing. Though immune complex-induced release from rabbit platelets (20) (21) (22) requires complement (29) , release from human platelets does not (25, 26) .
Bacteria may interact with immunoglobulin by nonimmune mechanisms as well as by the formation of antigen-antibody complexes. A cell wall component of many strains of staphylococci, known as protein A, reacts with the Fc region of several IgG subclasses (30, 31) . Although some strains of pneumococcus also react with the Fc region in a nonimmune manner (32) , it is unlikely that the platelet release studied here is induced by such a mechanism. Rather (32) . In addition, myeloma proteins at concentrations of 2 mg/ml failed to support release whereas as little as 0.05 mg/rnl of normal IgG sufficed Finally, neither isolated Fc or Fab fragments of normal IgG (at 2 and 3 mg/ml, respectively) supported release, though the intact parent IgG did so at 0.05 mg/ml.
It is not known to what extent this mechanism contributes to the interaction of other microorganisms with platelets. Viral antigen-antibody complexes have been shown to induce platelet agglutination (33) . Streptococcal and staphylococcal-induced platelet release and aggregation have been shown to be supported by IgG, though the characteristics of the preparation used were not specified. Unlike pneumococcal-induced release, streptococcal-and staphylococcal-induced release was also supported by fibrinogen (4) .
The stimulus giving rise to the antibodies capable of interacting with pneumonococcus to promote platelet serotonin release is not known. Clinically inapparent pneumococcal infection might be responsible, as might antigens giving rise to cross-reacting antibodies (34) . Regardless of their cause, their presence in all normal sera tested suggests a potential role for them in the thrombocytopenia occurring during infection with this organism.
